MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析

◆英語タイトル:MiMedx Group Inc (MDXG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH83319FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MiMedx Group Inc (MiMedx) develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation, and enhance healing. The company offers services in the areas of wound care, burn, surgical, orthopaedic, spine, sports medicine, ophthalmic and dental sectors of healthcare. MiMedx is headquartered in Marietta, Georgia, the US.

MiMedx Group Inc Key Recent Developments

Mar 30,2021: MiMedx awarded amniotic tissue supplier agreement with Premier’s SURPASS Purchasing Program
Mar 08,2021: MiMedx announces fourth quarter and full year 2020 financial and operating results
Mar 03,2021: MiMedx to Participate at Upcoming Investor Conferences

This comprehensive SWOT profile of MiMedx Group Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MiMedx Group Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

MiMedx Group Inc – Key Information
MiMedx Group Inc – Overview
MiMedx Group Inc – Key Employees
MiMedx Group Inc – Key Employee Biographies
MiMedx Group Inc – Key Operational Heads
MiMedx Group Inc – Major Products and Services
MiMedx Group Inc – History
MiMedx Group Inc – Company Statement
MiMedx Group Inc – Locations And Subsidiaries
MiMedx Group Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

MiMedx Group Inc – Business Description
MiMedx Group Inc – Corporate Strategy
MiMedx Group Inc – SWOT Analysis
SWOT Analysis – Overview
MiMedx Group Inc – Strengths
MiMedx Group Inc – Weaknesses
MiMedx Group Inc – Opportunities
MiMedx Group Inc – Threats
MiMedx Group Inc – Key Competitors

Section 3 – Company Financial Performance Charts

MiMedx Group Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

MiMedx Group Inc, Key Information
MiMedx Group Inc, Key Ratios
MiMedx Group Inc, Share Data
MiMedx Group Inc, Major Products and Services
MiMedx Group Inc, History
MiMedx Group Inc, Key Employees
MiMedx Group Inc, Key Employee Biographies
MiMedx Group Inc, Key Operational Heads
MiMedx Group Inc, Other Locations
MiMedx Group Inc, Subsidiaries
MiMedx Group Inc, Key Competitors
MiMedx Group Inc, SWOT Analysis
MiMedx Group Inc, Ratios based on current share price
MiMedx Group Inc, Annual Ratios
MiMedx Group Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chevron Corp (CVX):石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for, produces and transports crude oi …
  • Novaliq GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops dermatological products, novel ophthalmic, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears a preserva …
  • Aptiv Plc:企業の戦略・SWOT・財務分析
    Aptiv Plc - Strategy, SWOT and Corporate Finance Report Summary Aptiv Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析
    Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Rex Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Rex Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Rex Energy Corp (Rex Energy) is an independent energy company. It carries out the acquisition, production, exploration and development of condensate, natural gas and natural gas liquids. It holds pro …
  • Procter & Gamble Hygiene and Health Care Ltd:企業の戦略・SWOT・財務分析
    Procter & Gamble Hygiene and Health Care Ltd - Strategy, SWOT and Corporate Finance Report Summary Procter & Gamble Hygiene and Health Care Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • CSL Ltd (CSL):医療機器:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Sumitomo Electric Industries Ltd (5802):企業の財務・戦略的SWOT分析
    Sumitomo Electric Industries Ltd (5802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Jardine Cycle & Carriage Limited:企業の戦略・SWOT・財務情報
    Jardine Cycle & Carriage Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Cycle & Carriage Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Lay Hong Berhad (Lay Hong):企業の財務・戦略的SWOT分析
    Lay Hong Berhad (Lay Hong) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Epigenomics AG (ECX):企業の製品パイプライン分析
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • EVN AG (EVN):企業の財務・戦略的SWOT分析
    EVN AG (EVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Zavante Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops novel therapies for the treatment of infectious diseases such as due to multi-drug resistant (MDR) bacteria. The company offers drugs for the treatment of diseases …
  • Alliant Energy Corporation:企業の戦略・SWOT・財務分析
    Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliant Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Jeronimo Martins SGPS SA:企業の戦略・SWOT・財務情報
    Jeronimo Martins SGPS SA - Strategy, SWOT and Corporate Finance Report Summary Jeronimo Martins SGPS SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alkane Energy Plc:電力:M&Aディール及び事業提携情報
    Summary Alkane Energy Plc (Alkane Energy), a subsidiary of Basalt Infrastructure Partners LLP, is a diversified company. The company power from coal mine methane and natural gas facilities. It has natural gas, coal bed methane, coal mine methane and shale gas. Alkane Energy design, builds and operat …
  • Cogent Communications Holdings inc (CCOI):企業の財務・戦略的SWOT分析
    Cogent Communications Holdings inc (CCOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆